에서 이용할 수 있어요!
자세히 알아보기
Karyopharm Therapeutics
KPTI
KPTI
상장폐지됨
KPTI 종목은 2026년 11월 10일에 상장 폐지됐어요.
소개: Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
직원 수: 228
뉴스
긍정적
중립
부정적
투자 심리
3개월
긍정적
0%
중립
100%
부정적
0%
가격 차트는 Lightweight Charts™ 라이브러리로 구현했어요